Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-052120
Filing Date
2023-10-04
Accepted
2023-10-04 19:26:06
Documents
1
Period of Report
2023-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18250
  Complete submission text file 0001209191-23-052120.txt   19627
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VENTYX BIOSCIENCES, INC. 332 ENCINITAS BLVD. SUITE 200 ENCINITAS CA 92024
Business Address
Nuss John (Reporting) CIK: 0001874108 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 231309391